Xiangling Feng Selected Research

sulindac sulfide amide

2/2016

Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangling Feng Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 09/2005
6	Nasopharyngeal Carcinoma 04/2020 - 09/2005
5	Multiple Myeloma 11/2022 - 01/2020
5	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2015
5	Nasopharyngitis 11/2014 - 09/2005
3	Carcinogenesis 01/2021 - 06/2013
1	Hepatocellular Carcinoma (Hepatoma) 02/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2021
1	Inflammation (Inflammations) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Hyperuricemia 09/2020
1	Gout 09/2020
1	Asthma (Bronchial Asthma) 04/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2019
1	Pneumonia (Pneumonitis) 04/2019
1	Neuroblastoma 01/2019
1	Breast Neoplasms (Breast Cancer) 02/2016
1	Hyperplasia 06/2013
1	Embryonal Carcinoma 01/2012
1	Germinoma 01/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2013
4	Bortezomib (Velcade)FDA Link 01/2022 - 01/2020
4	Messenger RNA (mRNA)IBA 11/2014 - 01/2007
3	MicroRNAs (MicroRNA)IBA 01/2018 - 03/2014
2	Glutathione (Reduced Glutathione)IBA 11/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2005
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 04/2019
2	Serine (L-Serine)FDA Link 01/2021 - 01/2020
2	flotillinsIBA 04/2020 - 07/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2022
1	Sincalide FDA Link 02/2022
1	GalactosidasesIBA 02/2022
1	TensinsIBA 02/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	dacomitinibIBA 10/2021
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2021
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 06/2021
1	ArsenicIBA 06/2021
1	mecobalamin (methylcobalamin)IBA 06/2021
1	fisetinIBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Methionine (L-Methionine)FDA Link 01/2021
1	FYX-051IBA 09/2020
1	Uric Acid (Urate)IBA 09/2020
1	Xanthine DehydrogenaseIBA 09/2020
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2020
1	Beclin-1IBA 01/2020
1	Formaldehyde (Formol)FDA Link 04/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	MicrocystinsIBA 01/2019
1	Hypoxia-Inducible Factor 1IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Butyric Acid (Butanoic Acid)IBA 02/2017
1	Histone Deacetylase InhibitorsIBA 02/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2016
1	Sulindac (Copal)FDA LinkGeneric 02/2016
1	sulindac sulfideIBA 02/2016
1	ProstaglandinsIBA 02/2016
1	sulindac sulfide amideIBA 02/2016
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2016
1	LipidsIBA 07/2015
1	AntibodiesIBA 04/2015
1	Biological ProductsIBA 06/2013
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	LactoferrinIBA 07/2011
1	pectenotoxin 1IBA 01/2007

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 09/2018
1	Surgical Amputation (Amputations) 01/2022
1	Radiotherapy 09/2018
1	Chemoprevention 02/2016